Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and kidney disease.
North America dominated the global NSAID API market due to high demand for APIs in drug formulations and research and development programs in this region. The region is expected to continue its dominance in the coming years owing to increasing preference for generic medicines as a result of high healthcare costs in the U.S. Among other regions, Asia-Pacific is the next largest market for APIs. This region has become the most attractive market due to clustering of a large number of generic medicine manufacturers.
Market Analysis and Insights: Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market
The global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market.
Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Scope and Market Size
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Paracetamol
Ibuprofen
Aspirin
Naproxen
Others
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Based on regional and country-level analysis, the Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
Novartis
Pfizer
Boehringer Ingelheim
Teva Pharmaceutical
Hospira
Lonza Group
Mylan
Aurobindo Pharma
Dr. Reddy's Laboratories
Actavis
Wuxi Apptec
Zhejiang NHU
North America dominated the global NSAID API market due to high demand for APIs in drug formulations and research and development programs in this region. The region is expected to continue its dominance in the coming years owing to increasing preference for generic medicines as a result of high healthcare costs in the U.S. Among other regions, Asia-Pacific is the next largest market for APIs. This region has become the most attractive market due to clustering of a large number of generic medicine manufacturers.
Market Analysis and Insights: Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market
The global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market.
Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Scope and Market Size
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
Paracetamol
Ibuprofen
Aspirin
Naproxen
Others
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Based on regional and country-level analysis, the Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Novartis
Pfizer
Boehringer Ingelheim
Teva Pharmaceutical
Hospira
Lonza Group
Mylan
Aurobindo Pharma
Dr. Reddy's Laboratories
Actavis
Wuxi Apptec
Zhejiang NHU
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
